Unlock instant, AI-driven research and patent intelligence for your innovation.

Neutralizing antibodies targeting USAG-1 molecules for dental regeneration therapy

A USAG-1, antibody technology, applied in the direction of antibodies, biochemical equipment and methods, prostheses, etc., can solve the problems that tissue engineering methods have not yet reached clinical application

Pending Publication Date: 2022-04-15
KYOTO UNIV +2
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, tissue engineering methods have not yet reached clinical application due to the cost and safety concerns of securing the cell source

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Neutralizing antibodies targeting USAG-1 molecules for dental regeneration therapy
  • Neutralizing antibodies targeting USAG-1 molecules for dental regeneration therapy
  • Neutralizing antibodies targeting USAG-1 molecules for dental regeneration therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0139] Preparation of Antibody 1

[0140] To prepare mouse USAG-1 neutralizing antibody, human USAG-1 protein derived from Escherichia coli expression system (R&D systems) was used as an antigen. In a Wnt reporter gene assay using HEK293 cells, the Wnt inhibitory activity of the human USAG-1 protein derived from the E. coli expression system was confirmed ( figure 1 ). In an ALP assay using C2C12 cells supplemented with BMP7, the BMP inhibitory activity of the human USAG-1 protein derived from the E. coli expression system was confirmed ( figure 2 ). To prepare mouse USAG-1 neutralizing antibodies, three USAG-1 KO mouse lines (#116, #118, #138) were newly established using CRISPR-CAS9 ( image 3 ). Neutralizing antibodies were prepared by the iliac lymph node method using USAG-1 KO (#116) mice in ITM Co., Ltd.

[0141] 284 wells were initially screened by ELISA using the immune antigen, and a large number of positive wells were found ( Pic 4-1 and Figure 4-2 ). Ba...

Embodiment 2

[0146] Antibody In Vitro Test-1

[0147] Mouse USAG-1 (WISE) recombinant protein with PA tag added to the N-terminus was transiently expressed in Expi293F cells, and a stable expression line was established. Affinity purification was performed using the PA labeling system, and 0.2 mg PA-mUSAG-1 (WISE) was obtained from 150 mL culture supernatant ( Figure 5 ). The reduction (R) and non-reduction (NR) electrophoresis showed that the molecular weight of the purified PA-mUSAG-1 (WISE) protein was about 28kDa, which was close to the theoretical value (24kDa). The N-terminal PA-tagged mouse USAG-1 (WISE) protein derived from the Expi293F cell expression system in mammalian cells showed dose-dependent WNT signaling inhibitory activity in a WNT reporter assay ( Figure 6 ) and showed dose-dependent BMP signaling inhibitory activity in the BMP ALP assay ( Figure 7 ). The neutralizing activity of five kinds of mouse anti-USAG-1 neutralizing antibodies (E12, E16, E37, E48, E57) w...

Embodiment 3

[0150] In vivo administration test of antibody-1

[0151] Congenital hypodontia model mice with homozygous EDA deficiency have a high loss (about 90%) of mandibular third molars (M3). A single dose of mouse anti-USAG-1 neutralizing antibody A (E37) was intraperitoneally administered to a dam carrying a model mouse for congenital tooth hypoplasia due to EDA deficiency. As a result, 7 out of 8 born EDA-deficient mice recovered the loss of the mandibular third molar (M3) ( Figure 10 ). No supernumerary teeth were observed in EDA-deficient congenital tooth hypoplasia model mice administered with mouse anti-USAG-1 neutralizing antibody A. Thus, Antibody A was found to repair missing teeth. Here, the term "restored" means that a born EDA-deficient mouse has teeth where EDA-deficient mice would normally lose teeth (without missing M3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

An antibody or antigen binding fragment thereof that specifically binds to and neutralizes USAG-1 is provided; and a pharmaceutical composition containing the antibody or antigen-binding fragment.

Description

technical field [0001] The present invention relates to neutralizing antibodies targeting USAG-1 for the treatment of tooth hypoplasia or tooth regeneration. Background technique [0002] Acquired diseases such as dental caries and periodontal disease cause hypodontia (patients with missing teeth) in most patients. The incidence of congenital hypodontia has also been reported to be as high as 1%. Currently, the only treatment for missing teeth is restorative treatment, including dental implants and dentures, and there is no fundamental cure. Many studies using tissue engineering methods for tooth regeneration have been reported. Various cells such as stem cells (Non-Patent Document 1) are used as a cell source. In addition, in order to make teeth produced in vitro function in the oral cavity, the "organ primordium method" (Non-Patent Document 2), a cell manipulation technique, was reported to regenerate tooth organ primordia in collagen gels (the prototype of an organ). ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/18C12N15/13A61K39/395A61L27/22A61P1/02A61P43/00
CPCC07K16/18A61L27/22A61P1/02A61P43/00A61K2039/505C07K2317/565C07K2317/56C07K2317/76C07K2317/34C07K2317/92C07K16/22C07K2317/24
Inventor 高桥克菅井学时田义人高木淳一三原惠美子
Owner KYOTO UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More